Related references
Note: Only part of the references are listed.Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients
Aydan Eroglu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2007)
Heparanase, heparin and the coagulation system in cancer progression
Israel Vlodavsky et al.
THROMBOSIS RESEARCH (2007)
Venous thromboembolic disease and cancer
A. Fennerty
POSTGRADUATE MEDICAL JOURNAL (2006)
Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer
Sandra Battistelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Deep vein thrombosis in cancer: the scale of the problem and approaches to management
A Falanga et al.
ANNALS OF ONCOLOGY (2005)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients
M Kennedy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter
M Mandalà et al.
ANNALS OF ONCOLOGY (2004)
Increased incidence of neoplasia with persistent activation of the of the digestive tract in men coagulant pathway
GJ Miller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation
MR Taliani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma
R Pihusch et al.
CANCER (2002)
The clinical course of deep vein thrombosis in patients with gynecologic cancer
MA Morgan et al.
GYNECOLOGIC ONCOLOGY (2002)
Resistance to activated protein C, factor V Leiden and the prothrombin G20210A variant in patients with colorectal cancer
GA Paspatis et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)